DeKalb, Illinois Clinical Trials

A listing of DeKalb, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 22 clinical trials
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

open biopsy
cancer
bevacizumab
metastatic colorectal cancer
adjuvant therapy
Northwestern Medicine Cancer Center Delnor
 (22.8 away) Contact site
  • 65 views
  • 27 Jul, 2021
  • +978 other locations
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relationships, sexuality and sexual activity, and mental health. This study will evaluate how well elagolix in combination with combined oral contraceptives (COC) works within the body and/or how safe it …

elagolix
endometriosis
combined oral contraceptives
dysmenorrhea
New Beginnings Obstetrics & Gynecology /ID# 217227
 (7.0 away) Contact site
  • 396 views
  • 26 Jul, 2021
  • +202 other locations
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma the EQUATE Trial

This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as lenalidomide, …

cancer
prednisone
neutrophil count
electrophoresis
dexamethasone
Northwestern Medicine Cancer Center Delnor
 (22.8 away) Contact site
  • 0 views
  • 21 Jul, 2021
  • +365 other locations
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

This randomized phase III trial studies how well hypofractionated radiation therapy works in preventing recurrence in patients with stage IIa-IIIa cancer who have undergone mastectomy. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells that remain after surgery …

cancer
beta-human chorionic gonadotropin
mastectomy
carcinoma
carcinoma in situ
Northwestern Medicine Cancer Center Delnor
 (22.8 away) Contact site
  • 335 views
  • 28 Jul, 2021
  • +911 other locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial enrolls participants for …

serous adenocarcinoma
germ cell tumor of ovary
teratoma
carcinoid
cancer of the ovary
Northwestern Medicine Cancer Center Delnor
 (22.8 away) Contact site
  • 6047 views
  • 01 Aug, 2021
  • +814 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

cancer
carcinoma
adenocarcinoma
metastasis
lung cancer
Northwestern Medicine Cancer Center Delnor
 (22.8 away) Contact site
  • 1103 views
  • 01 Aug, 2021
  • +1138 other locations
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic …

dabrafenib
heart failure
prednisone
targeted therapy
cutaneous squamous cell carcinoma
Northwestern Medicine Cancer Center Delnor
 (22.8 away) Contact site
  • 6087 views
  • 01 Aug, 2021
  • +1020 other locations
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

This randomized phase III trial studies how well olanzapine with or without fosaprepitant work in preventing chemotherapy induced nausea and vomiting in cancer patients receiving chemotherapy that causes vomiting. Olanzapine and fosaprepitant dimeglumine may help control nausea and vomiting in patients during chemotherapy. Olanzapine is usually given in combination with …

primary cancer
treatment regimen
vomiting
bilateral oophorectomy
nausea
Northwestern Medicine Cancer Center Delnor
 (22.8 away) Contact site
  • 109 views
  • 29 Jul, 2021
  • +603 other locations
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer The PDIGREE Study

This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and nivolumab, followed by nivolumab with cabozantinib in patients with untreated renal cell carcinoma that has spread to other parts of the body. The addition of cabozantinib to the …

cancer
programmed cell death 1 ligand 1
carcinoma
il-2
neutrophil count
Northwestern Medicine Cancer Center Delnor
 (22.8 away) Contact site
  • 157 views
  • 01 Aug, 2021
  • +677 other locations
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission

This randomized phase III trial studies rituximab after stem cell transplant and to see how well it works compared with rituximab alone in treating patients with in minimal residual disease-negative mantle cell lymphoma in first complete remission. Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells …

vincristine
cancer
prednisone
cyclin d1
rituximab
Northwestern Medicine Cancer Center Kishwaukee
 (2.0 away) Contact site
  • 258 views
  • 24 Jul, 2021
  • +238 other locations